Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin plus metformin versus linagliptin alone in newly diagnosed treatment-naive type 2 diabetes
2011-004158-24Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin monotherapy with Linagliptin + metformin (2 arms). Primary endpoint: Change from baseline in glycated hemoglobin. Started Jan 2012; status: completed.
02
Drugs
linagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-004158-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004158-24.